A clinical study based on novel Coronavirus intelligent robot for nasopharyngeal swab sampling

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035985

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Sample from oropharynx and nasopharynx by medical staff.

Index test:Sample&#32

from&#32

nasopharynx&#32

by&#32

intelligent&#32

robot.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for outpatients 1. Obtain a signed written informed consent; 2. The chief complaint is nasal discomfort; 3. Aged >= 18 years old, regardless of gender. Inclusion criteria for the general population 1. Obtain a signed written informed consent; 2. Aged >= 18 years old.

Exclusion criteria

Exclusion criteria: Conditions deemed inappropriate for inclusion by the researcher.

Design outcomes

Primary

Measure	Time frame
Sampling efficiency and accuracy;	—

Countries

China

Contacts

Public ContactBin Shen

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

binlion1982@163.com+86 13301856068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026